购物车
- 全部删除
- 您的购物车当前为空
VEGFR-2-IN-9 (KDR-in-4) 是一种高效的 KDR/VEGFR2 抑制剂(IC50:7 nM),可用于研究乳腺癌。
VEGFR-2-IN-9 (KDR-in-4) 是一种高效的 KDR/VEGFR2 抑制剂(IC50:7 nM),可用于研究乳腺癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 4,900 | 8-10周 | |
5 mg | ¥ 12,600 | 8-10周 |
产品描述 | VEGFR-2-IN-9 (KDR-in-4) is a potent KDR/VEGFR2 inhibitor (IC50: 7 nM). It can be used to study breast cancer. |
靶点活性 | KDR:7 nM |
体外活性 | One of the human tyrosine kinases with a high affinity for vascular endothelial growth factor (VEGF) is KDR (kinase insert domain-containing receptor), believed to be a primary mediator of tumor-induced angiogenesis[2]. |
体内活性 | KDR-in-4, at doses of 100 mg/kg, results in a 98% reduction in lesion size in the rat choroidal neovascularization (CNV) model, demonstrating potential utility for the treatment of various ocular neovascular diseases through a convenient oral dosing regimen. In the laser CNV and rat oxygen-induced retinopathy (OIR) models, 30 mg/kg doses of KDR-in-4 exhibit reductions in lesion size of 70% and 80%, respectively[1]. |
别名 | KDR-in-4 |
分子量 | 391.46 |
分子式 | C23H25N3O3 |
CAS No. | 408502-06-7 |
Smiles | O=C1NC=2C=CC=CC2C=C1C3=CC4=CC(OCCN(C)CCOC)=CC=C4N3 |
密度 | 1.235 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容